Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

NLG919

Base Information Edit
NLG919

Synonyms:rac-5-(2-hydroxyl(cyclohexylethyl))-5H-imidazo[5,1-a]isoindole

Suppliers and Price of NLG919
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • NLG919
  • 10mg
  • $ 150.00
  • Medical Isotopes, Inc.
  • NLG919
  • 10 mg
  • $ 650.00
  • Medical Isotopes, Inc.
  • NLG919
  • 50 mg
  • $ 1050.00
  • Matrix Scientific
  • 1-Cyclohexyl-2-(5H-imidazo-[5,1-a]isoindol-5-yl)ethanol 97%
  • 1g
  • $ 1080.00
  • Matrix Scientific
  • 1-Cyclohexyl-2-(5H-imidazo-[5,1-a]isoindol-5-yl)ethanol 97%
  • 500mg
  • $ 591.00
  • DC Chemicals
  • NLG919(GDC-0919) >99%
  • 1 g
  • $ 800.00
  • DC Chemicals
  • NLG919(GDC-0919) >99%
  • 250 mg
  • $ 400.00
  • Crysdot
  • NLG919 98+%
  • 100mg
  • $ 399.00
  • Crysdot
  • NLG919 98+%
  • 50mg
  • $ 228.00
  • ChemScene
  • IDO-IN-7 99.87%
  • 50mg
  • $ 288.00
Total 50 raw suppliers
Chemical Property of NLG919 Edit
Chemical Property:
  • Melting Point:143 - 146°C 
  • Boiling Point:524.6±33.0 °C(Predicted) 
  • PKA:14.85±0.20(Predicted) 
  • Density:1.27±0.1 g/cm3(Predicted) 
  • Storage Temp.:-20°C 
  • Solubility.:Soluble in DMSO (up to 15 mg/ml) 
Purity/Quality:

99% *data from raw suppliers

NLG919 *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Description (±)-NLG-919 is an indoleamine 2,3-dioxygenase (IDO) pathway inhibitor (Ki = 7 nM; EC50 = 75 nM). (±)-NLG-919 inhibits IDO-induced T cell suppression and restores T cell response during allogenic mixed lymphocyte reactions in vitro (ED50s = 80 and 120 nM, respectively). In vivo, (±)-NLG-919 induces a 95% reduction in tumor volume when administered in conjunction with a pmel-1 T cell vaccine. Formulations containing (±)-NLG-919 are under investigation in clinical trials for treatment of glioblastoma, melanoma, pancreatic, and breast cancers.
  • Uses NLG919 is a potent indoleamine-2,3-dioxygenase (IDO) pathway inhibitor and is suitable for the treatment of immunosuppression associated with cancer.
Technology Process of NLG919

There total 10 articles about NLG919 which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With sodium tetrahydroborate; In methanol; at 0 ℃; for 0.5h;
Guidance literature:
Multi-step reaction with 3 steps
1.1: sodium hydride / tetrahydrofuran / 0.25 h / 0 °C
1.2: 2.5 h / 20 °C
2.1: acetic acid / methanol / 2 h / 90 °C
3.1: sodium tetrahydroborate / methanol / 0.5 h / 0 °C
With sodium tetrahydroborate; sodium hydride; acetic acid; In tetrahydrofuran; methanol;
Refernces Edit
Post RFQ for Price